Oncotarget is an oncology-focused, peer-reviewed, open access journal founded in 2010. It covers research on all aspects of oncology and is indexed by MEDLINE/PubMed and PMC/PubMed. The journal publishes papers continuously within yearly volumes and releases them quickly to PubMed. Oncotarget is based in the United States and operates in the biotechnology, health care, and publishing industries. Currently, there is no publicly available information regarding its last investment or investors. To ensure scientific integrity, the company has implemented a rigorous process outlined on their website.
General Information
Get notified when Oncotarget moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Oncotarget
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Oncotarget
Taxonomy: Oncology, Cancer Research, Biomedical Journal, Open Access Publishing, Peer-Review, MEDLINE, PMC, Scientific Integrity, Hematology, Tumor Research
No funding data available for Oncotarget yet.
Get notified when Oncotarget raises fundingOncotarget Alternatives & Competitors
Innovative Bioresearch Ltd is a biotech company introducing a "decentralized science" model with the...
Providing Custom Content Management System Service
GenomeUp is medical software that uses AI to create a detailed clinical report for doctors.
FAQ About Oncotarget
Don't just browse. Track.
Signal Tracker monitors Oncotarget and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.